Skye Bioscience SG&A Expense (Quarterly) Analysis

Skye Bioscience Inc (SKYE)

11.95 +0.19 (+1.62%) USD | NASDAQ | Jun 03, 16:00

11.95 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	4.206M
December 31, 2023	2.495M
September 30, 2023	2.236M
June 30, 2023	1.206M
March 31, 2023	1.915M
December 31, 2022	1.540M
September 30, 2022	1.141M
June 30, 2022	1.791M
March 31, 2022	1.622M
December 31, 2021	1.348M
September 30, 2021	1.491M
June 30, 2021	0.949M
March 31, 2021	1.128M
December 31, 2020	0.9489M
September 30, 2020	1.192M
June 30, 2020	0.7921M
March 31, 2020	1.412M
December 31, 2019	1.128M
September 30, 2019	0.9901M
June 30, 2019	1.083M
March 31, 2019	1.194M
December 31, 2018	1.078M
September 30, 2018	0.9783M
June 30, 2018	1.080M
March 31, 2018	1.226M

Date	Value
December 31, 2017	0.9165M
September 30, 2017	0.6731M
June 30, 2017	0.6703M
March 31, 2017	1.288M
December 31, 2016	0.6489M
September 30, 2016	0.7756M
June 30, 2016	1.022M
March 31, 2016	1.085M
December 31, 2015	0.8112M
September 30, 2015	0.744M
June 30, 2015	1.313M
March 31, 2015	0.8726M
December 31, 2014	1.668M
September 30, 2014	0.6626M
July 31, 2014	0.0334M
April 30, 2014	0.046M
January 31, 2014	0.0298M
October 31, 2013	0.04M
July 31, 2013	0.0395M
April 30, 2013	0.0401M
January 31, 2013	0.0289M
October 31, 2012	0.0057M
July 31, 2012	0.0001M
April 30, 2012	0.0006M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.7921M

Minimum

Jun 2020

4.206M

Maximum

Mar 2024

1.531M

Average

1.277M

Median

SG&A Expense (Quarterly) Benchmarks